BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28164136)

  • 1. The Role of Humoral Alloreactivity in Liver Transplantation: Lessons Learned and New Perspectives.
    Cheng EY
    J Immunol Res; 2017; 2017():3234906. PubMed ID: 28164136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increasing clinical importance of alloantibodies in kidney transplantation.
    Pankewycz O; Soliman K; Laftavi MR
    Immunol Invest; 2014; 43(8):775-89. PubMed ID: 25296233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-mediated rejection in pediatric liver transplant recipients.
    Markiewicz-Kijewska M; Kaliciński P; Kluge P; Piątosa B; Rękawek A; Jankowska I; Kostecka E; Kurowski PN
    Ann Transplant; 2014 Mar; 19():119-23. PubMed ID: 24594760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
    Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
    World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The (re)emergence of B cells in organ transplantation.
    Stegall MD; Raghavaiah S; Gloor JM
    Curr Opin Organ Transplant; 2010 Aug; 15(4):451-5. PubMed ID: 20613525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update.
    Filippone EJ; Farber JL
    Clin Transplant; 2015 Apr; 29(4):279-87. PubMed ID: 25645090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of severe C4d-positive kidney allograft dysfunction in the absence of histomorphologic features of rejection.
    Habicht A; Regele H; Exner M; Soleiman A; Hörl WH; Watschinger B; Derfler K; Böhmig GA
    Wien Klin Wochenschr; 2002 Nov; 114(21-22):945-8. PubMed ID: 12528329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immunity and antibody-mediated rejection in solid organ transplantation.
    Montgomery RA; Cozzi E; West LJ; Warren DS
    Semin Immunol; 2011 Aug; 23(4):224-34. PubMed ID: 21958960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic sequelae of allosensitization in liver transplantation.
    Zimmerman MA; Schiller J; Kim J; Martin A; Selim M; Nydam TL; Cronin D; Hong JC
    J Surg Res; 2016 Jan; 200(1):195-9. PubMed ID: 26253457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral Immune Response and Allograft Function in Kidney Transplantation.
    Filippone EJ; Farber JL
    Am J Kidney Dis; 2015 Aug; 66(2):337-47. PubMed ID: 25987262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular helper T cells and humoral response in organ transplantation.
    Laguna-Goya R; Suàrez-Fernández P; Paz-Artal E
    Transplant Rev (Orlando); 2019 Oct; 33(4):183-190. PubMed ID: 31327572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
    Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
    Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant.
    Barth RN; Campos L; Kukuruga DL; Drachenberg C; Philosophe B
    Clin Transplant; 2010; 24(5):685-90. PubMed ID: 19925465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
    Pascual MA; Crespo M; Tolkoff-Rubin N
    Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral autoimmunity and transplant vasculopathy: when allo is not enough.
    Win TS; Pettigrew GJ
    Transplantation; 2010 Jul; 90(2):113-20. PubMed ID: 20531074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased humoral antibody episodes of acute renal allograft rejection in recipients expressing the HLA-DQβ1*0202 allele.
    Mannam VK; Santos M; Lewis RE; Cruse JM
    Exp Mol Pathol; 2012 Oct; 93(2):190-2. PubMed ID: 22609240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Int Immunopharmacol; 2017 Sep; 50():48-54. PubMed ID: 28628770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
    Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
    Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.